The Well VenturesTM portfolio includes more than a dozen companies that span our focus areas. For strategic reasons, we do not publicize all of our investments, but here are some of the companies we have supported:
ApniCure is developing and commercializing novel home-use devices for the treatment of obstructive sleep apnea (OSA) and other sleep related disorders. The Winx system is the first in a series of products intended to improve the lives of the millions of patients suffering from sleep disordered breathing. For more information, please visit www.apnicure.com
Aviary is a photo editor for web and mobile with over 70 million users worldwide. On Aviary, people edit, enhance and creatively transform their photos, making every image sharable and print-worthy. Available as a free app on iOS and Android, and as licensable software powering the photo editing experiences of over 7,000 web and mobile destinations, Aviary has been used over 10 billion times to effortlessly perfect and share beautiful images. On September 22, 2014, Aviary was acquired by Adobe.
CareMetx is transforming post-commercialization "hub" services for specialty pharmaceutical, biotech, and device manufacturers. The company delivers customized reimbursement, clinical, and patient management solutions for complex and often high-cost products. CareMetx focuses on supporting the patient journey from intake to outcomes. Its differentiator is the proprietary technology platform that integrates the hub, manages disparate data, and delivers robust reports through real time dashboards, portals and mobile apps. CareMetx clients achieve improved start of therapy, increased retention to prescribed treatment and enhanced support for patients and providers. Its management team has decades of experience having founded some of the leading specialty services and pharmacy providers serving people with rare, orphan and complex diseases. For more information, please visit www.caremetx.com
EXOS (formerly Athletes' Performance) is pioneering human performance. Founded in 1999 to maximize the potential of athletes, EXOS has grown to become a leader in proactive health and performance, trusted by elite athletes, the military and innovative companies worldwide. EXOS designs and delivers health and performance game plans that guide people to achieve higher levels of success. With world-class partners, facilities, technologies, and specialists spanning six continents, EXOS is progressing the intelligence behind human performance wherever necessary. For more information, please visit www.TeamEXOS.com.
Genoa Healthcare is a leading specialty pharmacy operator that is focused exclusively on serving the outpatient mental health community. The company partners with mental health providers, typically non-profit community mental health centers, to provide onsite pharmacy and related services in dedicated space leased from the provider. It operates more than 120 on-site pharmacies, with the majority of Genoas patients suffering from serious mental conditions such as schizophrenia, acute bipolar disorder, or severe depression. These individuals are dependent on daily medication to function and generally have multiple co-morbidities. The company strives to make a positive impact within each of its partner clinics, and improve care and outcomes for the individuals it serves. On July 15, 2014, Genoa was acquired by QOL Meds, a portfolio company of Nautic Partners.
MC10 reshapes electronics to make life better. We take conventional high-performance electronics, and turn them into body-integrated form factors that stretch, bend, and twist seamlessly with our bodies and the natural world. The technology has broad application across a number of industries including healthcare, consumer electronics, military, and industrial products, and within each industry has the potential to fundamentally change the way electronic systems are incorporated into products. For more information, please visit http://www.MC10inc.com.
Propeller Health (formerly Asthmapolis) is pioneering effective new digital therapeutic solutions for respiratory health management. The Propeller platform is designed to help patients and their physicians better understand and control asthma, COPD, and other respiratory disease to reduce preventable emergency room visits, hospitalizations, and unnecessary suffering. The FDA-cleared solution combines smartphone applications, analytics, services and inhaler sensors to help users increase adherence, better manage asthma and COPD, and help physicians identify worsening patients before they suffer a severe and costly exacerbation. For more information, please visit www.propellerhealth.com.
SoCore Energy is the market leader in solar portfolio development and commercial rooftop installations. Focused exclusively on the solar energy needs of multisite retailers, REITs and industrial clients, SoCore combines engineering excellence and financial innovation to reduce the operational and bottom-line expense of solar energy implementation, cut energy costs and hedge against utility-rate increases. The company has designed and installed solar solutions in 10 states, completed over 75 commercial scale installations and placed more than 100,000 solar panels on roofs nationwide. Known for our ability to provide innovative, effective solutions for sophisticated properties and challenging rooftops, SoCore completed one of the nation's largest solar energy rollouts for drugstore chain Walgreens. On August 5, 2013, SoCore Energy was acquired by Edison Commercial Energy Services and currently operates as a subsidiary of the company.